시장보고서
상품코드
1149676

미국의 재택 주입 요법 시장 규모 : 제품별, 용도별, 업계 분석, 지역별 전망, 성장 가능성, 가격 동향, 경쟁 시장 점유율, 예측(2023-2032년)

U.S. Home Infusion Therapy Market Size By Product, By Application, Industry Analysis Report, Zonal Outlook, Growth Potential, Price Trends, Competitive Market Share & Forecast, 2023 - 2032

발행일: | 리서치사: Global Market Insights Inc. | 페이지 정보: 영문 254 Pages | 배송안내 : 2-3일 (영업일 기준)

※ 본 상품은 영문 자료로 한글과 영문 목차에 불일치하는 내용이 있을 경우 영문을 우선합니다. 정확한 검토를 위해 영문목차를 참고해주시기 바랍니다.

미국의 재택 주입 요법 시장은 소비자의 재택의료 시스템에 대한 선호 상승에 의해 2032년까지 크게 성장할 것으로 예측됩니다. 기술 진보나 세계의 고령자 인구 증가가 시장 성장을 더욱 촉진하고 있습니다.

미국의 재택 주입 요법(Home Infusion Therapy) 시장에 대해 조사 분석했으며, 업계 인사이트, 부문 분석, 지역 분석, 기업 개요 등을 제공하고 있습니다.

목차

제1장 조사 방법과 범위

제2장 주요 요약

제3장 미국의 재택 주입 요법 업계 인사이트

  • 업계 세분화
  • 업계 상황(2018-2032년)
  • 업계의 영향요인
    • 성장 촉진요인
    • 업계의 잠재적 위험·과제
  • 성장 가능성 분석
    • 제품별
    • 용도별
  • COVID-19의 영향 분석
  • 재택 주입 요법을 소개하고 있는 병원·진료소 리스트
  • 신약 승인 시나리오(2021년)
    • 주요 적응 질환
    • 신약 승인(2010-2021년)
    • 신약 승인 리스트(2021년)
  • 재택 주입 요법 환자수(2018-2022년)
  • 상환 시나리오
  • 규제 상황
  • Porter's Five Forces 분석
  • PESTLE 분석

제4장 경쟁 상황(2021년)

  • 서론
  • 기업 매트릭스 분석(2021년)
  • 전략 대시보드(2021년)

제5장 미국의 재택 주입 요법 시장 : 제품별

  • 주요 부문 동향
  • 주입 펌프
  • 점적 세트
  • IV 캐뉼라
  • 무바늘 커넥터

제6장 미국의 재택 주입 요법 시장 : 용도별

  • 주요 부문 동향
  • 항감염증
  • 수분보급요법
  • 화학요법
  • 경장영양
  • 정맥영양
  • 특수 의약품
  • 기타

제7장 미국의 재택 주입 요법 시장 : 지역별

  • 주요 지역 동향
  • 동북 중부
    • 시장 규모 : 주(州)별(2018-2032년)
    • 시장 규모 : 제품별(2018-2032년)
    • 시장 규모 : 용도별(2018-2032년)
    • 일리노이
    • 인디애나
    • 미시간
    • 오하이오
    • 위스콘신
  • 서남 중부
    • 시장 규모 : 주(州)별(2018-2032년)
    • 시장 규모 : 제품별(2018-2032년)
    • 시장 규모 : 용도별(2018-2032년)
    • 아칸소
    • 루이지애나
    • 오클라호마
    • 텍사스
  • 남대서양
    • 시장 규모 : 주(州)별(2018-2032년)
    • 시장 규모 : 제품별(2018-2032년)
    • 시장 규모 : 용도별(2018-2032년)
    • 델라웨어
    • 플로리다
    • 조지아
    • 메릴랜드
    • 노스캐롤라이나
    • 사우스캐롤라이나
    • 버지니아
    • 웨스트버지니아
    • 워싱턴 DC
  • 북동
    • 시장 규모 : 주(州)별(2018-2032년)
    • 시장 규모 : 제품별(2018-2032년)
    • 시장 규모 : 용도별(2018-2032년)
    • 코네티컷
    • 메인
    • 매사추세츠
    • 뉴햄프셔
    • 로드아일랜드
    • 버몬트
    • 뉴저지
    • 뉴욕
    • 펜실베이니아
  • 동남 중부
    • 시장 규모 : 주(州)별(2018-2032년)
    • 시장 규모 : 제품별(2018-2032년)
    • 시장 규모 : 용도별(2018-2032년)
    • 앨라배마
    • 켄터키
    • 미시시피
    • 테네시
  • 서북 중부
    • 시장 규모 : 주(州)별(2018-2032년)
    • 시장 규모 : 제품별(2018-2032년)
    • 시장 규모 : 용도별(2018-2032년)
    • 아이오와
    • 캔자스
    • 미네소타
    • 미저리
    • 네브래스카
    • 노스다코타
    • 사우스다코타
  • 퍼시픽 센트럴
    • 시장 규모 : 주(州)별(2018-2032년)
    • 시장 규모 : 제품별(2018-2032년)
    • 시장 규모 : 용도별(2018-2032년)
    • 알래스카
    • 캘리포니아
    • 하와이
    • 오리건
    • 워싱턴
  • 산악부
    • 시장 규모 : 주(州)별(2018-2032년)
    • 시장 규모 : 제품별(2018-2032년)
    • 시장 규모 : 용도별(2018-2032년)
    • 애리조나
    • 콜로라도
    • 유타
    • 네바다
    • 뉴멕시코
    • 아이다호
    • 몬태나
    • 와이오밍

제8장 기업 개요

  • B. Braun Melsungen AG
  • Baxter International Inc.
  • Becton Dickinson and Company
  • Fresenius Kabi
  • ICU Medical Inc.
  • Terumo Corporation
  • Moog Inc.
  • Halyard Health, Inc.(Avanos Medical)
  • Amsino International, Inc.
  • Lepu Medical Technology
  • Erenler Medikal
  • Contec Medical Systems Co. Ltd
  • JMS Co. Ltd.
KSM 22.11.24

The U.S. home infusion therapy market is expected to grow substantially through 2032 owing to the growing preference of consumers towards at-home healthcare systems.

Advancements in technology and the increasing geriatric population across the world have further fueled the market growth. Several renowned companies in the industry are vying for overseas expansion and better opportunities to grow their business in developing states across the US.

In the region, preferences for homecare settings are changing because of increased chronic disease frequency and healthcare costs. One of the frequent inflammatory and autoimmune diseases identified in home healthcare situations is rheumatoid arthritis.

In addition to this, the home infusion therapy demand as well as I.V. infusion therapy is rising as a result of the growing number of sick people, thus positively affecting the market demand.

Furthermore, strategic initiatives like mergers, acquisitions, and product launches by leading industry players would as well expand the market scope for home infusion therapy in the United States. For instance, in September 2022, B. Braun Medical Inc., a global leader in pain management and infusion therapy, revealed the takeover of Starboard Medical, Inc.'s unique Clik-FIX catheter securement device portfolio.

With peripheral intravenous (IV) therapy, B. Braun's purchase expands on the firm's portfolio of product and program innovation to improve patient experiences and outcomes.

The U.S. home infusion therapy market has been divided in terms of product, application, and zone.

Based on the product, the IV cannulas segment is set to witness ample growth in the market through the forthcoming years. The fundamental purpose of IV cannulas is to deliver antibiotics, fluids, and blood products intravenously with an intent to enhance the condition for which a patient is being treated.

In terms of application, the U.S. home infusion therapy market has been categorized into hydration therapy, anti-infective, enteral nutrition, specialty pharmaceuticals, chemotherapy, and parenteral nutrition.

The hydration therapy segment is slated to proliferate significantly over 2023-2032. Meanwhile, the chemotherapy segment is projected to register considerable growth by the end of 2032. Furthermore, parenteral nutrition is also set to showcase a strong market share over the forecast years. The others segment is expected to expand exponentially through the review timeline.

With respect to zone, the U.S. home infusion therapy industry is diversified into east north central, west south central, east south central, west north central, and mountain states. The east-north central segment is poised to foresee steady growth through the forthcoming years. On the other hand, the mountain states segment is speculated to advance substantially by the end of 2032.

Table of Contents

Chapter 1 Methodology & Scope

  • 1.1 Market definitions
  • 1.2 Base estimates and working
  • 1.3 Forecast parameters
  • 1.4 Data validation
  • 1.5 Data sources
    • 1.5.1 Secondary
      • 1.5.1.1 Paid sources
      • 1.5.1.2 Unpaid sources
    • 1.5.2 Primary

Chapter 2 Executive Summary

  • 2.1 U.S. home infusion therapy industry 360 degree synopsis, 2018 - 2032
    • 2.1.1 Business trends
    • 2.1.2 Product trends
    • 2.1.3 Application trends
    • 2.1.4 Zone trends

Chapter 3 US Home Infusion Therapy Industry Insights

  • 3.1 Industry segmentation
  • 3.2 Industry landscape, 2018 - 2032
  • 3.3 Industry impact forces
    • 3.3.1 Growth drivers
      • 3.3.1.1 Growing hospital acquired infections
      • 3.3.1.2 Rising prevalence of chronic diseases
      • 3.3.1.3 Advancements in technology
      • 3.3.1.4 Growing geriatric population
      • 3.3.1.5 Increasing preference towards at-home healthcare solutions
    • 3.3.2 Industry pitfalls & challenges
      • 3.3.2.1 Safety concerns and risk of failure associated with home infusion devices
  • 3.4 Growth potential analysis
    • 3.4.1 By product
    • 3.4.2 By application
  • 3.5 COVID- 19 impact analysis
  • 3.6 List of hospitals/clinics referring home infusion therapy
  • 3.7 New drug approval scenario, 2021
    • 3.7.1 Major disease indications
    • 3.7.2 New drug approvals, 2010 - 2021
    • 3.7.3 List of new drug approvals, 2021
  • 3.8 Number of home infusion therapy patients 2018 - 2022
  • 3.9 Reimbursement scenario
    • 3.9.1 Public payer reimbursement scenario
    • 3.9.2 Private payer reimbursement scenario
    • 3.9.3 Reimbursement or billing scenario by companies
    • 3.9.4 Future trends in reimbursement and billing
  • 3.10 Regulatory landscape
  • 3.11 Porter's analysis
    • 3.11.1 Industry rivalry
    • 3.11.2 Suppliers power
    • 3.11.3 Buyer power
    • 3.11.4 Threat of substitute
    • 3.11.5 Threat of new entrants
  • 3.12 PESTLE Analysis
    • 3.12.1 Political
    • 3.12.2 Economical
    • 3.12.3 Social
    • 3.12.4 Technological
    • 3.12.5 Legal
    • 3.12.6 Environmental

Chapter 4 Competitive Landscape, 2021

  • 4.1 Introduction
  • 4.2 Company matrix analysis, 2021
  • 4.3 Strategy dashboard, 2021

Chapter 5 US Home Infusion Therapy Market, By Product

  • 5.1 Key segment trends
  • 5.2 Infusion pumps
    • 5.2.1 Market size, by zone, 2018 - 2032 (USD Million)
  • 5.3 Intravenous sets
    • 5.3.1 Market size, by zone, 2018 - 2032 (USD Million)
  • 5.4 IV Cannulas
    • 5.4.1 Market size, by zone, 2018 - 2032 (USD Million)
  • 5.5 Needleless connectors
    • 5.5.1 Market size, by zone, 2018 - 2032 (USD Million)

Chapter 6 US Home Infusion Therapy Market, By Application

  • 6.1 Key segment trends
  • 6.2 Anti-infective
    • 6.2.1 Market size, by zone, 2018 - 2032 (USD Million)
  • 6.3 Hydration therapy
    • 6.3.1 Market size, by zone, 2018 - 2032 (USD Million)
  • 6.4 Chemotherapy
    • 6.4.1 Market size, by zone, 2018 - 2032 (USD Million)
  • 6.5 Enteral nutrition
    • 6.5.1 Market size, by zone, 2018 - 2032 (USD Million)
  • 6.6 Parenteral nutrition
    • 6.6.1 Market size, by zone, 2018 - 2032 (USD Million)
  • 6.7 Specialty pharmaceuticals
    • 6.7.1 Market size, by zone, 2018 - 2032 (USD Million)
  • 6.8 Others
    • 6.8.1 Market size, by zone, 2018 - 2032 (USD Million)

Chapter 7 US Home Infusion Therapy Market, By Zone

  • 7.1 Key zonal trends
  • 7.2 East North Central
    • 7.2.1 Market size, by state, 2018 - 2032 (USD Million)
    • 7.2.2 Market size, by product, 2018 - 2032 (USD Million)
    • 7.2.3 Market size, by application, 2018 - 2032 (USD Million)
    • 7.2.4 Illinois
      • 7.2.4.1 Market size, by product, 2018 - 2032 (USD Million)
      • 7.2.4.2 Market size, by application, 2018 - 2032 (USD Million)
    • 7.2.5 Indiana
      • 7.2.5.1 Market size, by product, 2018 - 2032 (USD Million)
      • 7.2.5.2 Market size, by application, 2018 - 2032 (USD Million)
    • 7.2.6 Michigan
      • 7.2.6.1 Market size, by product, 2018 - 2032 (USD Million)
      • 7.2.6.2 Market size, by application, 2018 - 2032 (USD Million)
    • 7.2.7 Ohio
      • 7.2.7.1 Market size, by product, 2018 - 2032 (USD Million)
      • 7.2.7.2 Market size, by application, 2018 - 2032 (USD Million)
    • 7.2.8 Wisconsin
      • 7.2.8.1 Market size, by product, 2018 - 2032 (USD Million)
      • 7.2.8.2 Market size, by application, 2018 - 2032 (USD Million)
  • 7.3 West South Central
    • 7.3.1 Market size, by state, 2018 - 2032 (USD Million)
    • 7.3.2 Market size, by product, 2018 - 2032 (USD Million)
    • 7.3.3 Market size, by application, 2018 - 2032 (USD Million)
    • 7.3.4 Arkansas
      • 7.3.4.1 Market size, by product, 2018 - 2032 (USD Million)
      • 7.3.4.2 Market size, by application, 2018 - 2032 (USD Million)
    • 7.3.5 Louisiana
      • 7.3.5.1 Market size, by product, 2018 - 2032 (USD Million)
      • 7.3.5.2 Market size, by application, 2018 - 2032 (USD Million)
    • 7.3.6 Oklahoma
      • 7.3.6.1 Market size, by product, 2018 - 2032 (USD Million)
      • 7.3.6.2 Market size, by application, 2018 - 2032 (USD Million)
    • 7.3.7 Texas
      • 7.3.7.1 Market size, by product, 2018 - 2032 (USD Million)
      • 7.3.7.2 Market size, by application, 2018 - 2032 (USD Million)
  • 7.4 South Atlantic
    • 7.4.1 Market size, by state, 2018 - 2032 (USD Million)
    • 7.4.2 Market size, by product, 2018 - 2032 (USD Million)
    • 7.4.3 Market size, by application, 2018 - 2032 (USD Million)
    • 7.4.4 Delaware
      • 7.4.4.1 Market size, by product, 2018 - 2032 (USD Million)
      • 7.4.4.2 Market size, by application, 2018 - 2032 (USD Million)
    • 7.4.5 Florida
      • 7.4.5.1 Market size, by product, 2018 - 2032 (USD Million)
      • 7.4.5.2 Market size, by application, 2018 - 2032 (USD Million)
    • 7.4.6 Georgia
      • 7.4.6.1 Market size, by product, 2018 - 2032 (USD Million)
      • 7.4.6.2 Market size, by application, 2018 - 2032 (USD Million)
    • 7.4.7 Maryland
      • 7.4.7.1 Market size, by product, 2018 - 2032 (USD Million)
      • 7.4.7.2 Market size, by application, 2018 - 2032 (USD Million)
    • 7.4.8 North Carolina
      • 7.4.8.1 Market size, by product, 2018 - 2032 (USD Million)
      • 7.4.8.2 Market size, by application, 2018 - 2032 (USD Million)
    • 7.4.9 South Carolina
      • 7.4.9.1 Market size, by product, 2018 - 2032 (USD Million)
      • 7.4.9.2 Market size, by application, 2018 - 2032 (USD Million)
    • 7.4.10 Virginia
      • 7.4.10.1 Market size, by product, 2018 - 2032 (USD Million)
      • 7.4.10.2 Market size, by application, 2018 - 2032 (USD Million)
    • 7.4.11 West Virginia
      • 7.4.11.1 Market size, by product, 2018 - 2032 (USD Million)
      • 7.4.11.2 Market size, by application, 2018 - 2032 (USD Million)
    • 7.4.12 Washington, D.C.
      • 7.4.12.1 Market size, by product, 2018 - 2032 (USD Million)
      • 7.4.12.2 Market size, by application, 2018 - 2032 (USD Million)
  • 7.5 North East
    • 7.5.1 Market size, by state, 2018 - 2032 (USD Million)
    • 7.5.2 Market size, by product, 2018 - 2032 (USD Million)
    • 7.5.3 Market size, by application, 2018 - 2032 (USD Million)
    • 7.5.4 Connecticut
      • 7.5.4.1 Market size, by product, 2018 - 2032 (USD Million)
      • 7.5.4.2 Market size, by application, 2018 - 2032 (USD Million)
    • 7.5.5 Maine
      • 7.5.5.1 Market size, by product, 2018 - 2032 (USD Million)
      • 7.5.5.2 Market size, by application, 2018 - 2032 (USD Million)
    • 7.5.6 Massachusetts
      • 7.5.6.1 Market size, by product, 2018 - 2032 (USD Million)
      • 7.5.6.2 Market size, by application, 2018 - 2032 (USD Million)
    • 7.5.7 New Hampshire
      • 7.5.7.1 Market size, by product, 2018 - 2032 (USD Million)
      • 7.5.7.2 Market size, by application, 2018 - 2032 (USD Million)
    • 7.5.8 Rhode Island
      • 7.5.8.1 Market size, by product, 2018 - 2032 (USD Million)
      • 7.5.8.2 Market size, by application, 2018 - 2032 (USD Million)
    • 7.5.9 Vermont
      • 7.5.9.1 Market size, by product, 2018 - 2032 (USD Million)
      • 7.5.9.2 Market size, by application, 2018 - 2032 (USD Million)
    • 7.5.10 New Jersey
      • 7.5.10.1 Market size, by product, 2018 - 2032 (USD Million)
      • 7.5.10.2 Market size, by application, 2018 - 2032 (USD Million)
    • 7.5.11 New York
      • 7.5.11.1 Market size, by product, 2018 - 2032 (USD Million)
      • 7.5.11.2 Market size, by application, 2018 - 2032 (USD Million)
    • 7.5.12 Pennsylvania
      • 7.5.12.1 Market size, by product, 2018 - 2032 (USD Million)
      • 7.5.12.2 Market size, by application, 2018 - 2032 (USD Million)
  • 7.6 East South Central
    • 7.6.1 Market size, by state, 2018 - 2032 (USD Million)
    • 7.6.2 Market size, by product, 2018 - 2032 (USD Million)
    • 7.6.3 Market size, by application, 2018 - 2032 (USD Million)
    • 7.6.4 Alabama
      • 7.6.4.1 Market size, by product, 2018 - 2032 (USD Million)
      • 7.6.4.2 Market size, by application, 2018 - 2032 (USD Million)
    • 7.6.5 Kentucky
      • 7.6.5.1 Market size, by product, 2018 - 2032 (USD Million)
      • 7.6.5.2 Market size, by application, 2018 - 2032 (USD Million)
    • 7.6.6 Mississippi
      • 7.6.6.1 Market size, by product, 2018 - 2032 (USD Million)
      • 7.6.6.2 Market size, by application, 2018 - 2032 (USD Million)
    • 7.6.7 Tennessee
      • 7.6.7.1 Market size, by product, 2018 - 2032 (USD Million)
      • 7.6.7.2 Market size, by application, 2018 - 2032 (USD Million)
  • 7.7 West North Central
    • 7.7.1 Market size, by state, 2018 - 2032 (USD Million)
    • 7.7.2 Market size, by product, 2018 - 2032 (USD Million)
    • 7.7.3 Market size, by application, 2018 - 2032 (USD Million)
    • 7.7.4 Iowa
      • 7.7.4.1 Market size, by product, 2018 - 2032 (USD Million)
      • 7.7.4.2 Market size, by application, 2018 - 2032 (USD Million)
    • 7.7.5 Kansas
      • 7.7.5.1 Market size, by product, 2018 - 2032 (USD Million)
      • 7.7.5.2 Market size, by application, 2018 - 2032 (USD Million)
    • 7.7.6 Minnesota
      • 7.7.6.1 Market size, by product, 2018 - 2032 (USD Million)
      • 7.7.6.2 Market size, by application, 2018 - 2032 (USD Million)
    • 7.7.7 Missouri
      • 7.7.7.1 Market size, by product, 2018 - 2032 (USD Million)
      • 7.7.7.2 Market size, by application, 2018 - 2032 (USD Million)
    • 7.7.8 Nebraska
      • 7.7.8.1 Market size, by product, 2018 - 2032 (USD Million)
      • 7.7.8.2 Market size, by application, 2018 - 2032 (USD Million)
    • 7.7.9 North Dakota
      • 7.7.9.1 Market size, by product, 2018 - 2032 (USD Million)
      • 7.7.9.2 Market size, by application, 2018 - 2032 (USD Million)
    • 7.7.10 South Dakota
      • 7.7.10.1 Market size, by product, 2018 - 2032 (USD Million)
      • 7.7.10.2 Market size, by application, 2018 - 2032 (USD Million)
  • 7.8 Pacific Central
    • 7.8.1 Market size, by state, 2018 - 2032 (USD Million)
    • 7.8.2 Market size, by product, 2018 - 2032 (USD Million)
    • 7.8.3 Market size, by application, 2018 - 2032 (USD Million)
    • 7.8.4 Alaska
      • 7.8.4.1 Market size, by product, 2018 - 2032 (USD Million)
      • 7.8.4.2 Market size, by application, 2018 - 2032 (USD Million)
    • 7.8.5 California
      • 7.8.5.1 Market size, by product, 2018 - 2032 (USD Million)
      • 7.8.5.2 Market size, by application, 2018 - 2032 (USD Million)
    • 7.8.6 Hawaii
      • 7.8.6.1 Market size, by product, 2018 - 2032 (USD Million)
      • 7.8.6.2 Market size, by application, 2018 - 2032 (USD Million)
    • 7.8.7 Oregon
      • 7.8.7.1 Market size, by product, 2018 - 2032 (USD Million)
      • 7.8.7.2 Market size, by application, 2018 - 2032 (USD Million)
    • 7.8.8 Washington
      • 7.8.8.1 Market size, by product, 2018 - 2032 (USD Million)
      • 7.8.8.2 Market size, by application, 2018 - 2032 (USD Million)
  • 7.9 Mountain States
    • 7.9.1 Market size, by state, 2018 - 2032 (USD Million)
    • 7.9.2 Market size, by product, 2018 - 2032 (USD Million)
    • 7.9.3 Market size, by application, 2018 - 2032 (USD Million)
    • 7.9.4 Arizona
      • 7.9.4.1 Market size, by product, 2018 - 2032 (USD Million)
      • 7.9.4.2 Market size, by application, 2018 - 2032 (USD Million)
    • 7.9.5 Colorado
      • 7.9.5.1 Market size, by product, 2018 - 2032 (USD Million)
      • 7.9.5.2 Market size, by application, 2018 - 2032 (USD Million)
    • 7.9.6 Utah
      • 7.9.6.1 Market size, by product, 2018 - 2032 (USD Million)
      • 7.9.6.2 Market size, by application, 2018 - 2032 (USD Million)
    • 7.9.7 Nevada
      • 7.9.7.1 Market size, by product, 2018 - 2032 (USD Million)
      • 7.9.7.2 Market size, by application, 2018 - 2032 (USD Million)
    • 7.9.8 New Mexico
      • 7.9.8.1 Market size, by product, 2018 - 2032 (USD Million)
      • 7.9.8.2 Market size, by application, 2018 - 2032 (USD Million)
    • 7.9.9 Idaho
      • 7.9.9.1 Market size, by product, 2018 - 2032 (USD Million)
      • 7.9.9.2 Market size, by application, 2018 - 2032 (USD Million)
    • 7.9.10 Montana
      • 7.9.10.1 Market size, by product, 2018 - 2032 (USD Million)
      • 7.9.10.2 Market size, by application, 2018 - 2032 (USD Million)
    • 7.9.11 Wyoming
      • 7.9.11.1 Market size, by product, 2018 - 2032 (USD Million)
      • 7.9.11.2 Market size, by application, 2018 - 2032 (USD Million)

Chapter 8 Company Profiles

  • 8.1 B. Braun Melsungen AG
    • 8.1.1 Business Overview
    • 8.1.2 Financial Data
    • 8.1.3 Product Landscape
    • 8.1.4 Strategic Outlook
    • 8.1.5 SWOT Analysis
  • 8.2 Baxter International Inc.
    • 8.2.1 Business Overview
    • 8.2.2 Financial Data
    • 8.2.3 Product Landscape
    • 8.2.4 Strategic Outlook
    • 8.2.5 SWOT Analysis
  • 8.3 Becton Dickinson and Company
    • 8.3.1 Business Overview
    • 8.3.2 Financial Data
    • 8.3.3 Product Landscape
    • 8.3.4 Strategic Outlook
    • 8.3.5 SWOT Analysis
  • 8.4 Fresenius Kabi
    • 8.4.1 Business Overview
    • 8.4.2 Financial Data
    • 8.4.3 Product Landscape
    • 8.4.4 Strategic Outlook
    • 8.4.5 SWOT Analysis
  • 8.5 ICU Medical Inc.
    • 8.5.1 Business Overview
    • 8.5.2 Financial Data
    • 8.5.3 Product Landscape
    • 8.5.4 Strategic Outlook
    • 8.5.5 SWOT Analysis
  • 8.6 Terumo Corporation
    • 8.6.1 Business Overview
    • 8.6.2 Financial Data
    • 8.6.3 Product Landscape
    • 8.6.4 Strategic Outlook
    • 8.6.5 SWOT Analysis
  • 8.7 Moog Inc.
    • 8.7.1 Business Overview
    • 8.7.2 Financial Data
    • 8.7.3 Product Landscape
    • 8.7.4 Strategic Outlook
    • 8.7.5 SWOT Analysis
  • 8.8 Halyard Health, Inc. (Avanos Medical)
    • 8.8.1 Business Overview
    • 8.8.2 Financial Data
    • 8.8.3 Product Landscape
    • 8.8.4 Strategic Outlook
    • 8.8.5 SWOT Analysis
  • 8.9 Amsino International, Inc.
    • 8.9.1 Business Overview
    • 8.9.2 Financial Data
    • 8.9.3 Product Landscape
    • 8.9.4 Strategic Outlook
    • 8.9.5 SWOT Analysis
  • 8.10 Lepu Medical Technology
    • 8.10.1 Business Overview
    • 8.10.2 Financial Data
    • 8.10.3 Product Landscape
    • 8.10.4 Strategic Outlook
    • 8.10.5 SWOT Analysis
  • 8.11 Erenler Medikal
    • 8.11.1 Business Overview
    • 8.11.2 Financial Data
    • 8.11.3 Product Landscape
    • 8.11.4 Strategic Outlook
    • 8.11.5 SWOT Analysis
  • 8.12 Contec Medical Systems Co. Ltd
    • 8.12.1 Business Overview
    • 8.12.2 Financial Data
    • 8.12.3 Product Landscape
    • 8.12.4 Strategic Outlook
    • 8.12.5 SWOT Analysis
  • 8.13 JMS Co. Ltd.
    • 8.13.1 Business Overview
    • 8.13.2 Financial Data
    • 8.13.3 Product Landscape
    • 8.13.4 Strategic Outlook
    • 8.13.5 SWOT Analysis
비교리스트
0 건의 상품을 선택 중
상품 비교하기
전체삭제